Illumina Inc. (ILMN): Price and Financial Metrics


Illumina Inc. (ILMN): $359.06

-6.88 (-1.88%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ILMN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 459

in industry

ILMN POWR Grades


  • Quality is the dimension where ILMN ranks best; there it ranks ahead of 66.18% of US stocks.
  • The strongest trend for ILMN is in Growth, which has been heading down over the past 163 days.
  • ILMN's current lowest rank is in the Growth metric (where it is better than 1.18% of US stocks).

ILMN Stock Summary

  • ILMN has a higher market value than 95.58% of US stocks; more precisely, its current market capitalization is $59,462,772,000.
  • The price/operating cash flow metric for Illumina Inc is higher than 95.92% of stocks in our set with a positive cash flow.
  • With a price/sales ratio of 13.89, Illumina Inc has a higher such ratio than 89.38% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Illumina Inc, a group of peers worth examining would be ZM, PANW, TWLO, CRWD, and TTD.
  • Visit ILMN's SEC page to see the company's official filings. To visit the company's web site, go to www.illumina.com.

ILMN Valuation Summary

  • In comparison to the median Healthcare stock, ILMN's EV/EBIT ratio is 133.79% higher, now standing at 68.5.
  • Over the past 243 months, ILMN's price/sales ratio has gone down 111.2.
  • ILMN's price/sales ratio has moved down 111.2 over the prior 243 months.

Below are key valuation metrics over time for ILMN.

Stock Date P/S P/B P/E EV/EBIT
ILMN 2021-08-31 16.9 12.9 87.3 68.5
ILMN 2021-08-30 16.9 12.9 87.3 68.5
ILMN 2021-08-27 17.2 13.2 88.7 69.7
ILMN 2021-08-26 17.4 13.3 89.9 70.7
ILMN 2021-08-25 18.0 13.8 93.1 73.2
ILMN 2021-08-24 17.7 13.6 91.6 72.0

ILMN Growth Metrics

    Its 4 year price growth rate is now at 115.77%.
  • Its 5 year revenue growth rate is now at 57.84%.
  • Its 3 year net income to common stockholders growth rate is now at 105.31%.
Over the past 67 months, ILMN's revenue has gone up $2,027,040,000.

The table below shows ILMN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 4,280 669 906
2021-06-30 3,966 1,094 768
2021-03-31 3,473 1,081 630
2020-12-31 3,239 1,080 656
2020-09-30 3,238 1,117 638
2020-06-30 3,351 1,231 693

ILMN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ILMN has a Quality Grade of B, ranking ahead of 94.64% of graded US stocks.
  • ILMN's asset turnover comes in at 0.489 -- ranking 48th of 75 Measuring and Control Equipment stocks.
  • AMOT, AATC, and TRMB are the stocks whose asset turnover ratios are most correlated with ILMN.

The table below shows ILMN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-04 0.489 0.686 0.187
2021-04-04 0.448 0.676 0.175
2021-01-03 0.439 0.680 0.173
2020-09-27 0.443 0.690 0.165
2020-06-28 0.464 0.703 0.174
2020-03-29 0.497 0.704 0.209

ILMN Price Target

For more insight on analysts targets of ILMN, see our ILMN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $459.00 Average Broker Recommendation 1.92 (Hold)

ILMN Stock Price Chart Interactive Chart >

Price chart for ILMN

ILMN Price/Volume Stats

Current price $359.06 52-week high $555.77
Prev. close $365.94 52-week low $341.03
Day low $356.90 Volume 159,799
Day high $363.24 Avg. volume 1,202,843
50-day MA $377.51 Dividend yield N/A
200-day MA $423.15 Market Cap 56.12B

Illumina Inc. (ILMN) Company Bio


Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencinggenotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California. (Source:Wikipedia)


ILMN Latest News Stream


Event/Time News Detail
Loading, please wait...

ILMN Latest Social Stream


Loading social stream, please wait...

View Full ILMN Social Stream

Latest ILMN News From Around the Web

Below are the latest news stories about Illumina Inc that investors may wish to consider to help them evaluate ILMN as an investment opportunity.

Bradley & Co. Private Wealth Management, LLC Buys iShares iBonds Dec 2030 Term Corporate ...

Investment company Bradley & Co. Private Wealth Management, LLC (Current Portfolio) buys iShares iBonds Dec 2030 Term Corporate ETF, iShares iBonds Dec 2031 Term Corporate ETF, iShares iBonds Dec 2026 Term Corporate ETF, Invesco BulletShares 2029 Corporate Bond ETF, iShares iBonds Dec 2028 Term Muni Bond ETF, sells iShares iBonds 2023 Term High Yield and Income ETF, iShares iBonds Dec 2021 Term Corporate ETF, iShares iBonds Dec 2024 Term Muni Bond ETF, iShares MSCI USA ESG Optimized ETF, Invesco

Yahoo | January 21, 2022

Telos Capital Management, Inc. Buys Illumina Inc, United Parcel Service Inc, Newell Brands Inc, ...

San Diego, CA, based Investment company Telos Capital Management, Inc. (Current Portfolio) buys Illumina Inc, United Parcel Service Inc, Newell Brands Inc, Williams-Sonoma Inc, iShares MSCI Emerging Markets ex China ETF, sells Activision Blizzard Inc, iShares Biotechnology ETF, Merck Inc, Aflac Inc, Caterpillar Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Telos Capital Management, Inc..

Yahoo | January 21, 2022

First United Bank & Trust Buys BTC iShares Core MSCI EAFE ETF, Invesco Preferred ETF, FIRST ...

Investment company First United Bank & Trust (Current Portfolio) buys BTC iShares Core MSCI EAFE ETF, Invesco Preferred ETF, FIRST TR EXCH VII, Vanguard ESG International Stock ETF, Altria Group Inc, sells Invesco National AMT-Free Municipal Bond ETF, iShares 1-3 Year Credit Bond ETF, Alibaba Group Holding, Vanguard Intermediate-Term Corporate Bond ETF, ARK Innovation ETF during the 3-months ended 2021Q4, according to the most recent filings of the investment company, First United Bank & Trust.

Yahoo | January 21, 2022

Encompass Wealth Advisors, Llc Buys AbbVie Inc, Coca-Cola Co, Freeport-McMoRan Inc, Sells Tesla ...

Investment company Encompass Wealth Advisors, Llc (Current Portfolio) buys AbbVie Inc, Coca-Cola Co, Freeport-McMoRan Inc, American Express Co, Sherwin-Williams Co, sells Tesla Inc, iShares Core 1-5 Year USD Bond ETF, Avaya Holdings Corp, Kyndryl Holdings Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Encompass Wealth Advisors, Llc.

Yahoo | January 20, 2022

Illumina to Announce Fourth Quarter & Full Year 2021 Financial Results on Thursday, February 10, 2022

Illumina, Inc. (NASDAQ: ILMN) today announced that it will issue results for the fourth quarter and full year 2021 following the close of market on Thursday, February 10, 2022.

Yahoo | January 20, 2022

Read More 'ILMN' Stories Here

ILMN Price Returns

1-mo N/A
3-mo -13.93%
6-mo -27.05%
1-year -11.62%
3-year 22.18%
5-year 122.92%
YTD -5.62%
2021 2.82%
2020 11.53%
2019 10.61%
2018 37.27%
2017 70.64%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.7032 seconds.